Join
Live feed
·
INSIDERFilingvia Quantisnow
Verve Therapeutics Inc. logo

Dorval Allison converted options into 1,875 shares and sold $6,343 worth of shares (554 units at $11.45), increasing direct ownership by 48% to 4,060 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VERV· Verve Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VERV (Verve Therapeutics Inc.) and more on Quantisnow.

Dorval Allison converted options into 1,875 shares and sold $6,343 worth of shares (554 units at $11.45), increasing direct ownership by 48% to 4,060 units (SEC Form 4) | Quantisnow